AbleDocs Inc. Announces the Acquisition of Diversa Docs ApS to Further the Reach of the Worldwide Leader in Document Accessibility Products and Services Throughout Scandinavia
6.4.2021 15:42:00 EEST | Business Wire | Press release
AbleDocs Inc. the leading PDF accessibility product and service provider, and Diversa Docs ApS, a recognized leader in PDF and Web Accessibility services announce their coming together to become the Scandinavian leader in PDF accessibility products and services.
With a long-standing record of collaboration, both companies’ founders and leadership teams couldn’t be more excited to leverage each other’s capabilities to offer their existing and new clients the best in PDF/UA products and services.
“Diversa Docs has consistently been recognized as a leader in excellence in delivering PDF/UA compliant and accessible PDFs, and this acquisition will allow our combined client base to benefit from the experience, and scale of our products and services throughout Scandinavia,” said AbleDocs’ President (GLOBAL), Adam Spencer. “With their amazing team and end user focused approach, they are the ideal partner for AbleDocs. With our combined effort, we can drive the creation of next-generation PDF accessibility services and solutions,” said Vice-President (SCANDINAVIA), Jens Bjerre Kirkegaard.
“Accessibility has always appealed to me because it combines a technical field with a humanistic one,” says CEO of Diversa Docs, Asbjørn Fangel-Hansen.
“Having worked for 12 years in the Danish public sector within accessibility and most recently as the owner of one of the leading companies in the field of accessibility in Denmark, I am very honored to be part of one of the absolute leading global players when it comes to accessible documents,” adds Fangel-Hansen.
The combination of AbleDocs and Diversa Docs will widen the global presence of AbleDocs for products, services, solution development, training, and localized document accessibility support across 49 languages to ensure clients receive the best offerings possible.
About Diversa Docs
Diversa Docs ApS was founded by Lars Holm-Sørensen and Asbjørn Fangel-Hansen in 2019 as a sister company to Diversa ApS. Since then, the company has developed into one of the leaders in Denmark in terms of document accessibility and the area in general.
About AbleDocs Inc.
AbleDocs was founded in 2019 as a conglomerate of PDF accessibility remediation service providers and has grown to have operations in Canada, Denmark, Germany, Switzerland, and the United States. Its founders have been making documents accessible for over 150 years combined experience and has since expanded its offerings to include a completely new approach to document accessibility strategies to include products for high volume document accessibility, document accessibility testing.
AbleDocs is the only company in the world to guarantee the compliance of every file they produce and back it with a $10,000,000 liability guarantee. Current offerings include ADService, ADGateway, ADScan, ADStream, ADLegacy, ADForms, axesWord and axesPDF.
For more information, visit https://www.abledocs.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210406005229/en/
Contact information
For media inquiries:
Gary MacKay, mediainquiries@abledocs.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Massive Gaming Secures MGA B2B License to Expand Global iGaming Partnerships23.3.2026 11:13:00 EET | Press release
Massive Gaming (MVG), a global iGaming content provider with headquarters in Australia, has secured a B2B Gaming License from the Malta Gaming Authority (MGA), marking a key milestone in the company’s expansion into regulated international markets. The MGA license enables Massive Gaming to supply its gaming content and solutions to operators licensed under the Malta regulatory framework, strengthening the company’s ability to collaborate with partners across Europe and other regulated jurisdictions. To support its regulatory expansion, Massive Gaming established MVG Malta, a dedicated entity created as part of the licensing process, and which supports the company’s broader strategy to strengthen its presence within the European iGaming ecosystem. Massive Gaming develops its gaming portfolio across three studios - Slot Mart, Whale House and Blitzcrown. All three deliver a range of gaming experiences spanning traditional slot titles, regulated market content and emerging non-traditional
LTM Expands BlueVerse ™ Tech with AppIQ, AgentIQ and FusionIQ to Accelerate AI‑Led Engineering23.3.2026 10:30:00 EET | Press release
LTM – the Business Creativity partner to the world’s largest enterprises, today announced the expansion of BlueVerseTM Tech, its AI‑led engineering platform, with the launch of AppIQ, AgentIQ and FusionIQ—three purpose‑built platforms designed to help enterprises modernize applications, orchestrate AI‑first software delivery, and engineer quality at scale. As software development evolves from human‑only execution to human + intelligent agents, traditional effort‑driven engineering and QA models are increasingly unable to keep pace. These BlueVerseTM platforms embed agentic, engineering‑aware AI across the software development lifecycle (SDLC), enabling enterprises to move faster from legacy complexity to modern, resilient, and high‑quality digital systems. AppIQ — Modernize Legacy Applications, Faster AppIQ applies AI to read and understand legacy codebases, generate documentation, map functional workflows, and produce actionable specifications for forward engineering. What previously
Galderma Receives U.S. FDA Approval for Restylane ® Contour™ for the Correction of Temple Hollowing23.3.2026 08:00:00 EET | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.1,2 This builds on its previous approvals for cheek augmentation and midface contour deficiencies, helping injectors address volume loss across key structural areas.1-3 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260322108467/en/ With the broadest Injectable Aesthetics portfolio in the industry, this follows the recent U.S. approval of Restylane Lyft for augmentation of the chin region, adding to its indications to treat the midface, facial folds and wrinkles, back of hands, and the chin.4,5 Together, these approvals demonstrate Galderma’s ongoing commitment to evolving the versatile Restylane portfolio to deliver personalized, natural-looking outcomes that meet diverse patient needs.1,4,6,7 The volume of the temples can dimi
Paving the Way for Real‑Time Earth Observation: Space Compass and SWISSto12 Sign Contract for First Commercial GEO Optical Data Relay Satellite23.3.2026 06:00:00 EET | Press release
Space Compass Corporation (“Space Compass”) and SWISSto12 SA (“SWISSto12”) announced today that they have executed a procurement contract for the first GEO optical data relay satellite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260320584108/en/ (From Left to Right): Julie Pignon, Legal Counsel, SWISSto12; 倉田 るり子 (Ruriko Kurata), Legal Counsel, Space Compass; 小松 大実 (Hiromi Komatsu), Co-CEO, Space Compass; 田中 良太 (Ryota Tanaka), Engineering Director, Space Compass; Emile de Rijk, CEO, SWISSto12; Fredrik Gustavsson, Chief Financial and Strategy Officer, SWISSto12. This agreement represents a major milestone toward the realization of Space Compass’s optical data relay service. With high-speed, high-capacity optical data relay service, Space Compass aims to transform Earth Observation from just a tracking record into a real-time decision-making tool. For SWISSto12, the contract represents further validation of the company’s a
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting20.3.2026 16:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that data from key programs in its Inflammation and Autoimmunity (IAI) franchise will be presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting, to be held March 27 – 31, 2026, in Denver. “At AAD 2026, we are presenting late‑breaking 54-week results from the Phase 3 STOP‑HS program evaluating povorcitinib in hidradenitis suppurativa (HS),” said Jim Lee, M.D., Ph.D., Group Vice President, Inflammation and Autoimmunity, Incyte. “These data provide longer term evidence of the safety and efficacy of povorcitinib in HS patients and further strengthen the significant growth potential of our Inflammation and Autoimmunity franchise.” Details on key data presentations at AAD include: Late-Breaking Oral Presentations Hidradenitis Suppurativa Povorcitinib in Patients With Moderate to Severe Hidradenitis Suppurativa: 54-Week Efficacy and Safety Results From the STOP-HS1 & STOP-HS2 Phase 3 Studies (Session: S034 – Late-Breaking Research: Sess
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom